Featured

24 January 2024

ACCORD: new guideline to support consistent and complete reporting of consensus methods in biomedical research

Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.

Learn more here
All
  • All
  • News
  • Articles
  • Events
May 27, 2022

Our industry partnership accelerates citation screening in systematic literature reviews by 25% with the help of artificial intelligence

Citation (title and abstract) screening for a systematic literature review may be accelerated by 25% through the application of artificial intelligence (AI) in a novel method developed by Oxford PharmaGenesis in partnership with Vyasa. The evidence reported in systematic literature reviews derives from articles that have passed a rigorous screening process. According to a recent study, our new,…

Continue reading
May 25, 2022

Exploring new frontiers in HealthScience communications at the 18th Annual Meeting of ISMPP

Creativity, diversity, data visualization and plain language summaries all took centre stage at the 18th Annual Meeting of the International Society for Medical Publication Professionals (ISMPP), which took place on 9–11 May 2022 in Washington, DC, USA.

Continue reading
May 10, 2022

Supply chain must innovate to support pharma's sustainability drive, urges study

Share this page As study finds that 95% of the top pharmaceutical companies worldwide aim to cut greenhouse gas emissions, commitments will require innovation and collaboration across the supply chain. Washington, DC, USA, 10 May 2022: According to a study presented at the 18th Annual Meeting of the International Society for Medical Publication Professionals (ISMPP) today, 19…

Continue reading
May 9, 2022

MAPS EMEA 2022 Annual Meeting

Oxford PharmaGenesis is proud to sponsor the MAPS 2022 EMEA Annual Meeting – the largest annual convention for Medical Affairs professionals in Europe, the Middle East and Africa. We are an award-winning, independent, global HealthScience consultancy. We take clients to new places with a range of transformative services. Our teams use innovative approaches, such as informatics, to explore new frontiers in strategic medical communications, informatics and data science, patient engagement, e-learning and value demonstration.

Continue reading
May 3, 2022

ISMPP US 2022 Global Annual Meeting

We’re helping medical publication professionals become future-ready at the 18th Annual Meeting of ISMPP 2022. Oxford PharmaGenesis is an award-winning, independent, global HealthScience consultancy. We innovate for clients through our transformative services. We offer expertise in publications, strategic medical communications, informatics and data science, patient engagement, value demonstration and Open Pharma.

Continue reading
April 8, 2022

Collaborating with Pfizer to identify cancer biomarkers: spotlighting our artificial intelligence (AI) and
informatics capabilities

Our Informatics and Data Science team has developed a paper, in collaboration with authors from Pfizer, that details a novel approach to identifying emerging cancer biomarkers. The paper, recently published in the journal Cancer Informatics, is accompanied by a publicly accessible, interactive dashboard to allow users to explore new insights around emerging biomarkers.

Continue reading